Cytomegalovirus infection trials in Brazil

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

  Where

  Porto Alegre, São Paulo

  Age

  Up to 17 years

  People

  80 worldwide

  Run by

  Takeda

  See details and how to joinNCT05319353 · EU 2023-508988-73-00